Allergies News and Research

Latest Allergies News and Research

TSRI scientists awarded two grants to develop new therapeutic target to reduce latent HIV infection

TSRI scientists awarded two grants to develop new therapeutic target to reduce latent HIV infection

CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

CU research suggests safe, lower-cost way to treat upper gastrointestinal tract problems in children

Emory University immunologists identify long-lived antibody-producing cells in bone marrow

Emory University immunologists identify long-lived antibody-producing cells in bone marrow

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Biosimilars show promise for children with IBD, but more research needed

Biosimilars show promise for children with IBD, but more research needed

Microbiota blocks the immune cells responsible for triggering allergies

Microbiota blocks the immune cells responsible for triggering allergies

University of Chicago Medicine named to FARE Clinical Network

University of Chicago Medicine named to FARE Clinical Network

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

FDA approves new heart failure drug

FDA approves new heart failure drug

New research reveals why some kids can have severe allergic reaction hours later

New research reveals why some kids can have severe allergic reaction hours later

Southern Research receives $22 million to support HIV cure initiative

Southern Research receives $22 million to support HIV cure initiative

Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

Biologically active molecules produced during gluten digestion can pass through gut lining

Biologically active molecules produced during gluten digestion can pass through gut lining

UChicago Medicine, Little Company of Mary partner to boost community access to specialty care for children

UChicago Medicine, Little Company of Mary partner to boost community access to specialty care for children

National trial aims to reduce unnecessary use of antibiotics in post-acute and long-term care facilities

National trial aims to reduce unnecessary use of antibiotics in post-acute and long-term care facilities

New technique that mines Twitter data can help identify potentially dangerous drug interactions

New technique that mines Twitter data can help identify potentially dangerous drug interactions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.